Detalhe da pesquisa
1.
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.
J Hepatol
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428641
2.
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving ß-blockers+ligation to prevent re-bleeding.
J Hepatol
; 80(1): 73-81, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852414
3.
Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial.
Hepatology
; 78(2): 530-539, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897269
4.
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements.
Hepatology
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916970
5.
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.
FASEB J
; 37(11): e23220, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801035
6.
Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study.
J Gastroenterol Hepatol
; 39(1): 149-156, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787176
7.
Evolving portal hypertension through Baveno VII recommendations.
Ann Hepatol
; 29(1): 101180, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984701
8.
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.
Gut
; 72(4): 749-758, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328772
9.
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
Gut
; 72(8): 1581-1591, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788015
10.
Beta-blockers in the era of precision medicine in patients with cirrhosis.
J Hepatol
; 78(4): 866-872, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529293
11.
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
J Hepatol
; 79(1): 69-78, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858157
12.
Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis.
J Hepatol
; 78(1): 114-122, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058365
13.
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.
J Hepatol
; 78(2): 390-400, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152767
14.
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure.
J Hepatol
; 79(1): 79-92, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268222
15.
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
N Engl J Med
; 383(16): 1522-1534, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558485
16.
Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.
Liver Int
; 43(9): 1984-1994, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443448
17.
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.
Liver Int
; 43(7): 1548-1557, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183551
18.
Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19.
Eur J Epidemiol
; 38(8): 883-889, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358671
19.
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
Dig Dis Sci
; 68(6): 2731-2737, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737575
20.
Exocrine pancreatic insufficiency and graft-versus-host disease.
Rev Esp Enferm Dig
; 115(4): 210-211, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148693